New drug may help those who can't take statins
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Cardiology
Nov 05, 2012 |
4 / 5 (3) |
0
|
Greater drop in LDL seen with atorvastatin plus PCSK9 antibody
(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) ...
Medical research
Nov 02, 2012 |
5 / 5 (1) |
0
Experts recommend screening adults for hypertriglyceridemia every five years
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of hypertriglyceridemia. Triglycerides are a type of fat found in the blood and are associated with cardiovascular risk. ...
Other
Sep 07, 2012 |
not rated yet |
0
Some improvement in heart risk factors for Americans: CDC
(HealthDay) -- About 47 percent of American adults have at least one risk factor for heart disease, according to a new report released Friday.
Health
Aug 03, 2012 |
not rated yet |
0
Low 'bad' cholesterol levels may be linked to cancer risk
(HealthDay) -- There may be a link between low levels of "bad" low-density lipoprotein (LDL) cholesterol and increased cancer risk, according to new research.
Cardiology
Mar 26, 2012 |
1 / 5 (1) |
0
|
Statin alternative looks promising in early trials
(HealthDay) -- Administration of REGN727, a monoclonal antibody to proprotein convertase subtilisin/kexin 9 (PCSK9), significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to the ...
Cardiology
Mar 22, 2012 |
3 / 5 (1) |
1
|
Soy-based S-equol supplement reduces metabolic syndrome risk factors
A 12-week treatment of the fermented soy germ-based nutritional supplement containing S-equol significantly lowered hemoglobin A1c (HbA1c), LDL cholesterol and improved vascular stiffness, all factors that occur as part of ...
Health
Mar 19, 2012 |
5 / 5 (1) |
0
New advance announced in reducing 'bad' cholesterol
Scientists from the University of Leicester and University of California Los Angeles (UCLA) have announced a breakthrough advance in tackling dangerous 'bad' cholesterol in the body.
Medical research
Dec 08, 2011 |
5 / 5 (1) |
0
|
With mutation, you can have your cream and eat it, too
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabo ...
Genetics
Dec 06, 2011 |
not rated yet |
0
|
Heart disease: Long-term study proves benefit of statins
Statins safely reduce the risk of cardiovascular illness even years after treatment is stopped, according to a probe into the popular cholesterol-busters published on Wednesday.
Cardiology
Nov 23, 2011 |
5 / 5 (1) |
11
Niacin does not reduce heart attack, stroke risk in stable CV patients
In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack and ...
Cardiology
Nov 15, 2011 |
3 / 5 (1) |
1
|
Women undergoing PCI display greater number of co-morbidities than men
New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated ...
Cardiology
Nov 01, 2011 |
not rated yet |
0
Obama 'fit at fifty': medical report
US President Barack Obama is "fit at fifty" after improving his cholesterol readings and kicking his smoking habit, according to results of his latest medical exam released Monday.
Health
Oct 31, 2011 |
not rated yet |
1
Divide over when to use in-depth cholesterol tests
For heart health, you're supposed to know your numbers: Total cholesterol, the bad LDL kind and the good HDL kind. But your next checkup might add a new number to the mix.
Health
Oct 24, 2011 |
4 / 5 (3) |
0
Targeting cholesterol to fight deadly brain cancers
Blocking the uptake of large amounts of cholesterol into brain cancer cells could provide a new strategy to battle glioblastoma, one of the most deadly malignancies, researchers at UCLA's Jonsson Comprehensive Cancer Center ...
Cancer
Sep 15, 2011 |
not rated yet |
0
|
